Poxel SA (France) Performance
| POXEL Stock | EUR 0.30 0.02 7.14% |
On a scale of 0 to 100, Poxel SA holds a performance score of 4. The company holds a Beta of 3.15, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Poxel SA will likely underperform. Please check Poxel SA's treynor ratio, semi variance, as well as the relationship between the Semi Variance and daily balance of power , to make a quick decision on whether Poxel SA's historical price patterns will revert.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Poxel SA are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Poxel SA reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 40.2 M | |
| Total Cashflows From Investing Activities | -42 K |
Poxel |
Poxel SA Relative Risk vs. Return Landscape
If you would invest 28.00 in Poxel SA on November 2, 2024 and sell it today you would earn a total of 2.00 from holding Poxel SA or generate 7.14% return on investment over 90 days. Poxel SA is generating 0.6967% of daily returns and assumes 11.8568% volatility on return distribution over the 90 days horizon. Simply put, majority of traded equity instruments are less risky than Poxel on the basis of their historical return distribution, and most equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Poxel SA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Poxel SA's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Poxel SA, and traders can use it to determine the average amount a Poxel SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0588
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | POXEL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.86 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.7 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Poxel SA is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Poxel SA by adding it to a well-diversified portfolio.
Poxel SA Fundamentals Growth
Poxel Stock prices reflect investors' perceptions of the future prospects and financial health of Poxel SA, and Poxel SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Poxel Stock performance.
| Return On Equity | -3.23 | |||
| Return On Asset | -0.3 | |||
| Operating Margin | (134.99) % | |||
| Current Valuation | 51.26 M | |||
| Shares Outstanding | 30.83 M | |||
| Price To Earning | 13.09 X | |||
| Price To Book | 5.34 X | |||
| Price To Sales | 162.16 X | |||
| Revenue | 13.4 M | |||
| EBITDA | (20.45 M) | |||
| Cash And Equivalents | 3.53 M | |||
| Cash Per Share | 2.58 X | |||
| Total Debt | 30.09 M | |||
| Debt To Equity | 25.50 % | |||
| Book Value Per Share | (0.12) X | |||
| Cash Flow From Operations | (16.89 M) | |||
| Earnings Per Share | (0.90) X | |||
| Total Asset | 54.89 M | |||
| Retained Earnings | (12 M) | |||
| Current Asset | 46 M | |||
| Current Liabilities | 7 M | |||
About Poxel SA Performance
Assessing Poxel SA's fundamental ratios provides investors with valuable insights into Poxel SA's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Poxel SA is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Poxel SA, a biopharmaceutical company, develops drugs for metabolic diseases with a primary focus on type II diabetes. The company was founded in 2009 and is headquartered in Lyon, France. Poxel SA operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 33 people.Things to note about Poxel SA performance evaluation
Checking the ongoing alerts about Poxel SA for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Poxel SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Poxel SA is way too risky over 90 days horizon | |
| Poxel SA has some characteristics of a very speculative penny stock | |
| Poxel SA appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 13.4 M. Net Loss for the year was (23.76 M) with profit before overhead, payroll, taxes, and interest of 13.34 M. | |
| Poxel SA has accumulated about 3.53 M in cash with (16.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.58, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Poxel SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Poxel SA's stock is overvalued or undervalued compared to its peers.
- Examining Poxel SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Poxel SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Poxel SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Poxel SA's stock. These opinions can provide insight into Poxel SA's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Poxel Stock Analysis
When running Poxel SA's price analysis, check to measure Poxel SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Poxel SA is operating at the current time. Most of Poxel SA's value examination focuses on studying past and present price action to predict the probability of Poxel SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Poxel SA's price. Additionally, you may evaluate how the addition of Poxel SA to your portfolios can decrease your overall portfolio volatility.